Resection Clinical Trials

93 recruitingLast updated: June 18, 2026

There are 93 actively recruiting resection clinical trials across 29 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include Guangzhou, Guangdong, China, Montpellier, France, Rouen, France. Updated daily from ClinicalTrials.gov.


Resection Trials at a Glance

93 actively recruiting trials for resection are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 47 trials, with the heaviest enrollment activity in Guangzhou, Montpellier, and Rouen. Lead sponsors running resection studies include Seoul National University Hospital, Beijing Tiantan Hospital, and Azienda USL Reggio Emilia - IRCCS.

Browse resection trials by phase

Treatments under study

About Resection Clinical Trials

Looking for clinical trials for Resection? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Resection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Resection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 93 trials

Recruiting
Not Applicable

Pre-incisional Infiltration With Ropivacaine Plus Diprospan for Relieving Postoperative Pain After Thoracoscopic Surgery

Video-assisted Thoracoscopic Surgery (VATS)SegmentectomyLobectomy+2 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07626489
Recruiting
Phase 1Phase 2

Safety of HRX215 in Patients After Minor and Major Liver Resection

Liver ResectionColorectal Carcinoma Liver Metastases
HepaRegeniX GmbH80 enrolled6 locationsNCT06638502
Recruiting
Not Applicable

Pre-incisional Infiltration With Ropivacaine Plus Triamcinolone for Relieving Postoperative Pain After Thoracoscopic Surgery

Video-assisted Thoracoscopic Surgery (VATS)SegmentectomyWedge Resection+3 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07603921
Recruiting
Not Applicable

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Postoperative ComplicationsAnastomotic LeaksAnastomotic Complication+8 more
Medtronic - MITG137 enrolled9 locationsNCT07351071
Recruiting
Not Applicable

Erector Spinae Plane Block Versus Thoracic Epidural Analgesia for Open Liver Resection

Liver CancerLiver NeoplasmsHepatic Resection
Nguyen Toan Thang60 enrolled1 locationNCT07642336
Recruiting
Not Applicable

Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

Crohn Disease (CD)Ileocolic ResectionPost-endoscopic Operative Reccurence
University Hospital, Clermont-Ferrand42 enrolled8 locationsNCT06972901
Recruiting
Not Applicable

Efficacy and Safety of Transcutaneous Posterior Tibial Nerve Stimulation on Fecal Continence in Patients Undergoing Surgery for Rectal Neoplasia

Quality of Life (QOL)Rectal Neoplasm MalignantFecal Incontinence (FI)+2 more
Althaia Xarxa Assistencial Universitària de Manresa84 enrolled2 locationsNCT07632196
Recruiting
Not Applicable

Implementation of a Pediatric ERAS-based Protocol in Intestinal Resection With Primary Anastomosis

Intestinal DiseasesIntestinal Resection
Michał Pasierbek120 enrolled9 locationsNCT07504549
Recruiting

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

Bladder (Urothelial, Transitional Cell) CancerBladder Cancer RecurrenceProgression of Bladder Cancer+2 more
Zhiping Wang150 enrolled1 locationNCT07589413
Recruiting
Phase 2Phase 3

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Radiotherapy Side EffectNeoadjuvant TherapyChemotherapy+8 more
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos400 enrolled1 locationNCT06758830
Recruiting
Not Applicable

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Bladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital196 enrolled6 locationsNCT07187635
Recruiting

Understanding and Tailored Treatment of Low Anterior Resection Syndrome

Colorectal (Colon or Rectal) Cancer SurvivorsLow Anterior Resection SyndromeFaecal Incontinence+1 more
Aalborg University Hospital145 enrolled3 locationsNCT07573371
Recruiting
Phase 3

Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance

Quality of Life (QOL)Rectal CancerLARS - Low Anterior Resection Syndrome+1 more
University Hospital, Basel, Switzerland140 enrolled5 locationsNCT06936774
Recruiting
Not Applicable

Stanford Program to Accelerate Robotic Children's Surgery

EndometriosisCholecystectomyHysterectomy+16 more
Stanford University250 enrolled1 locationNCT06671639
Recruiting
Not Applicable

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Rectal CarcinomaLow Anterior Resection Syndrome
Ohio State University Comprehensive Cancer Center80 enrolled1 locationNCT06424522
Recruiting

Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study

Early Colorectal CancerNon-curative Endoscopic Resection
Nanfang Hospital, Southern Medical University400 enrolled3 locationsNCT07542171
Recruiting
Phase 2

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

NSCLC Diagnosed by Histology or CytologyA Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical ResectionOverall Lung Function is Adequate for the Planned Lung Resection+1 more
Zhujiang Hospital46 enrolled1 locationNCT07534033
Recruiting
Not Applicable

Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary

Rectal CancerLARS - Low Anterior Resection Syndrome
KU Leuven158 enrolled1 locationNCT06274190
Recruiting
Phase 2Phase 3

Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.

Rectal CancerLow Anterior Resection Syndrome
Pei-Rong Ding160 enrolled1 locationNCT07537998
Recruiting

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Stage IIB-III NSCLCNeoadjuvant ChemoimmunotherapyRobotic Pulmonary Resection
Shanghai Chest Hospital200 enrolled10 locationsNCT07528066